These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 7521416

  • 1. [Correlation between histological features of liver biopsy specimens and clinical effect of interferon on patients with chronic hepatitis C].
    Kumagai N, Kuramochi S.
    Nihon Rinsho; 1994 Jul; 52(7):1769-73. PubMed ID: 7521416
    [Abstract] [Full Text] [Related]

  • 2. Assessment of histological features and outcome of interferon therapy in chronic hepatitis C.
    Kumagai N, Kuramochi S, Toda K, Iwabuchi N, Tsuchimoto K, Tsunematsu S, Saito H, Morizane T, Tsuchiya M, Ishii H.
    J Gastroenterol; 1996 Feb; 31(1):69-74. PubMed ID: 8808431
    [Abstract] [Full Text] [Related]

  • 3. Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon.
    García-Buey L, López-Botet M, García-Sánchez A, Balboa MA, Aramburu J, García-Monzón C, Acevedo A, Moreno-Otero R.
    Hepatology; 1993 Mar; 17(3):372-82. PubMed ID: 7680330
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Histological evaluation of the liver and response to interferon in chronic hepatitis C].
    Yoshida H, Iwabuchi S, Murayama M, Uchikoshi T.
    Nihon Rinsho; 1994 Jul; 52(7):1763-8. PubMed ID: 8078200
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997 Jul; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 Jul; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 17. Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.
    Taniguchi H, Iwasaki Y, Fujiwara A, Sakaguchi K, Moriya A, Yu PC, Takaki A, Fujioka S, Shimomura H, Shiratori Y.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):281-7. PubMed ID: 16460487
    [Abstract] [Full Text] [Related]

  • 18. Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults.
    Assy N, Minuk GY.
    Am J Gastroenterol; 2000 Jun; 95(6):1545-50. PubMed ID: 10894594
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C].
    Baba T, Makino R, Shibata M, Harada E, Mitamura K.
    Nihon Rinsho; 1997 Mar; 55(3):625-30. PubMed ID: 9086771
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.